WikiPathways:NewPathwayReleases2019
From WikiPathways
Contents |
202012
 Acetogenesis (Acetobacterium woodii) |
 RAS and Bradykinin pathways in COVID-19 (Homo sapiens) |
 Galanin receptor pathway (Homo sapiens) |
 CAMKK2 Pathway (Homo sapiens) |
 STING pathway in Kawasaki-like disease and COVID-19 (Homo sapiens) |
202011
 Deregulation of the Renin Angiotensin system by Sars-CoV infection (Mus musculus) |
 16p11.2 proximal deletion syndrome (Homo sapiens) |
 SARS-CoV-2 and COVID-19 Pathway (Homo sapiens) |
 aspirin and miRNAs (Homo sapiens) |
202010
 Glucocorticoid Receptor Pathway (Homo sapiens) |
 7q11.23 copy number variation syndrome (Homo sapiens) |
 DNA Repair Pathways Full Network (Homo sapiens) |
 16p11.2 distal deletion syndrome (Homo sapiens) |
 p53 transcriptional gene network (Homo sapiens) |
 Fluoroacetic acid toxicity (Homo sapiens) |
 Phosphoinositides metabolism (Homo sapiens) |
202009
 |
 |
 |
202008
 Beta Oxidation of Unsaturated Fatty Acids (Caenorhabditis elegans) |
202007
 MAPK pathway in congenital thyroid cancer (Homo sapiens) |
 15q11.2 copy number variation syndrome (Homo sapiens) |
 Mitochondrial Complex I inhibition leading to chemical induced fanconi syndrome (Homo sapiens) |
 NO metabolism in cystic fibrosis (Homo sapiens) |
202006
 EGFR Tyrosine Kinase Inhibitor Resistance (Homo sapiens) |
 The influence of laminopathies on Wnt signaling (Homo sapiens) |
 Linoleic acid metabolism known to be affected by coronavirus infection (Homo sapiens) |
 Endoplasmic reticulum (ER) stress response in Coronavirus infection (Homo sapiens) |
 SARS-CoV-2 and Angiotensin-converting enzyme 2 (ACE2) receptor: Molecular mechanisms and potential therapeutic target (Homo sapiens) |
 LDLRAD4 and what we know about it (Homo sapiens) |
 3q29 copy number variation syndrome (Homo sapiens) |
 COVID-19, thrombosis and anticoagulation (Homo sapiens) |
 Direct Reversal Repair (Homo sapiens) |
202005
 Mitochondrial CIV Assembly (Homo sapiens) |
 Autophagy (Homo sapiens) |
 Unfolded protein response (Homo sapiens) |
 MAP3K1 role in promoting and blocking gonadal determination (Homo sapiens) |
 Cellular Proteostasis (Homo sapiens) |
 Neuroinflammation (Homo sapiens) |
 Mitochondrial CII Assembly (Homo sapiens) |
 Mitochondrial CIII assembly (Homo sapiens) |
 Purinergic signaling (Homo sapiens) |
 1q21.1 copy number variation syndrome (Homo sapiens) |
 SARS coronavirus and innate immunity (Homo sapiens) |
 Proximal tubule transport (Homo sapiens) |
 Somatic Sex determination (Homo sapiens) |
 Peroxiredoxin 2 induced ovarian failure (Homo sapiens) |
 Disruption of postsynaptic signalling by CNV (Homo sapiens) |
 Interacting Laminopathic Pathways (Homo sapiens) |
 Peroxiredoxin 2 induced ovarian failure (Mus musculus) |
 Mammalian disorder of sexual development (Homo sapiens) |
202004
 Nanomaterial-induced Inflammasome Activation (Homo sapiens) |
 Oxidative Stress and Redox Pathway (Mus musculus) |
 Downregulation of ACE2 expression by SARS-CoV infection and SARS-CoV Spike protein. (Homo sapiens) |
 Ciliopathies (Homo sapiens)) |
 Cholesterol Biosynthesis with Skeletal Dysplasias (Homo sapiens) |
 Endochondral Ossification with Skeletal Dysplasias (Homo sapiens) |
 Glycosaminoglycan degradation (Homo sapiens) |
 Conversion of Angiotensinogen to Angiotensin II (Homo sapiens) |
 GDNF/RET signalling axis (Mus musculus) |
 Genes controlling renal nephrogenesis (Homo sapiens) |
 Regucalcin in proximal tubule epithelial kidney cells (Homo sapiens) |
 COVID-19 AOP (Homo sapiens) |
 Intracellular trafficking proteins involved in CMT neuropathy (Homo sapiens) |
 Hijack of Ubiquitination by SARS-CoV-2 (Homo sapiens) |
 Host-pathogen interaction of human corona viruses - autophagy (Homo sapiens) |
 Host-pathogen interaction of human corona viruses - apoptosis (Homo sapiens) |
|
Image does not exist Type I Interferon Induction and Signaling During SARS-CoV-2 Infection (Homo sapiens) |
 Kisspeptin/Kisspeptin Receptor System in the Ovary (Homo sapiens) |
 Activation of NLRP3 Inflammasome by SARS-CoV-2 (Homo sapiens) |
 Pathogenesis of SARS-CoV-2 Mediated by nsp9/nsp10 Complex (Homo sapiens) |
 Host-pathogen interaction of human corona viruses - MAPK signaling (Homo sapiens) |
 Host-pathogen interaction of human corona viruses - Interferon induction (Homo sapiens) |
202003
 Proteoglycan biosynthesis (Homo sapiens) |
 Somitogenesis in the context of spondylocostal dysostosis (Homo sapiens) |
 Type I collagen synthesis in the context of Osteogenesis imperfecta (Homo sapiens) |
 Osteoblast differentiation (Homo sapiens) |
 Autosomal recessive Osteopetrosis pathways (Homo sapiens) |
 MED and Pseudoachondroplasia genes (Homo sapiens) |
 FGF23 signalling in Hypophosphatemic rickets (Homo sapiens) |
 mBDNF and proBDNF regulation of GABA neurotransmission (Homo sapiens) |
 GDNF/RET signalling axis (Homo sapiens) |
202002
 FGFR3 signalling in chondrocyte proliferation and terminal differentiation (Homo sapiens) |
 Purine metabolism (Homo sapiens) |
 Monoterpene Biosynthesis Pathway Genes in Mint (Homo sapiens) |
202001
 Vitamin D-sensitive calcium signaling in depression (Homo sapiens) |
Image does not exist Thyroid hormones production and their peripheral downstream signalling effects regarding congenital hypothyroidism (Homo sapiens) |
 Netrin-UNC5B signaling Pathway (Homo sapiens) |
 Base Excision Repair (Homo sapiens) |
 Nucleotide Excision Repair (Homo sapiens) |
 IL-18 signaling pathway (Homo sapiens) |
 Renin Angiotensin Aldosterone System (RAAS) (Homo sapiens) |
 PKC-gamma calcium signaling pathway in ataxia (Homo sapiens) |
 Regulation of Pgc1a expression by a Gsk3b-Tfeb signaling axis in skeletal muscle (Mus musculus) |
201912
 Melanoma (Homo sapiens) |
 HIPK2 in kidney fibrosis (Homo sapiens) |
 Nephrotic syndrome (Homo sapiens) |
201911
 Fatty Acid Beta Oxidation (Rattus norvegicus) |
 Renin - Angiotensin System (Rattus norvegicus) |
 Glycerolipids and Glycerophospholipids (Homo sapiens) |
 Omega-9 FA synthesis (Homo sapiens) |
 Sphingolipid Metabolism (integrated pathway) (Homo sapiens) |
 Overview of interferons-mediated signaling pathway (Homo sapiens) |
 Omega-3/Omega-6 FA synthesis (Homo sapiens) |
 Relationship between inflammation, COX-2 and EGFR (Homo sapiens) |
 Eicosanoid metabolism via Cytochrome P450 Mono-Oxygenases (CYP) pathway (Homo sapiens) |
 Ketogenesis and Ketolysis (Homo sapiens) |
 Eicosanoid metabolism via Cyclo Oxygenases (COX) (Homo sapiens) |
 Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) (Homo sapiens) |
 Head and Neck Squamous Cell Carcinoma (Homo sapiens) |
 Eicosanoid metabolism via Lipo Oxygenases (LOX) (Homo sapiens) |
 Sphingolipid Metabolism (general overview) (Homo sapiens) |
201910
|
Image does not exist |
 |
 |
Image does not exist |
201909
 |
 |
 |
 |
 |
201908
 |
 |
 |
 |
|
Image does not exist |
 |
201907
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
201906
 |
 |
 |
|
 |
201905
 |
Image does not exist |
 |
201904
 |
 |
 |
 | |
 |
 |
 |
 |
 |
201903
 |
Image does not exist |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
201902
 |
 |
 |
 |
 |
 |
 |
 |
201901
 |
Image does not exist |
 |
 | |
 |
 |
 |
 | |
 |
 |
 |
 |
 |
